Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc. (SGRY)
:SGRY
SGRY Analyst Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SGRY Stock 12 Month Forecast
Average Price Target
$32.67
▲(36.41% Upside)
| Highest Price Target$36.00 | Average Price Target$32.67 | Lowest Price Target$28.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
Reiterated
03/24/25
Mizuho Securities
Reiterated
03/12/25
TD Cowen
Reiterated
03/05/25
Leerink Partners
Reiterated
03/04/25
KeyBanc
Reiterated
03/04/25
Benchmark Co.
Reiterated
03/04/25
Jefferies
Reiterated
03/03/25
Cantor Fitzgerald
Reiterated
02/03/25
Barclays
Assigned
01/29/25
Bank of America Securities
$30
Buy
25.26%
Upside
Assigned
12/16/24
Surgery Partners reinstated with a Buy at BofASurgery Partners reinstated with a Buy at BofA
J.P. Morgan
$38→$28
Hold
16.91%
Upside
Reiterated
12/03/24
Surgery Partners price target lowered to $28 from $38 at JPMorganSurgery Partners price target lowered to $28 from $38 at JPMorgan
Macquarie
―
Buy
―
Reiterated
11/19/24
Overreaction to Selloff: Surgery Partners' Undervalued Opportunity Amidst Strong Fundamentals
Citi
$38→$36
Buy
50.31%
Upside
Reiterated
08/07/24
Surgery Partners price target lowered to $36 from $38 at CitiSurgery Partners price target lowered to $36 from $38 at Citi
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Reiterated
03/24/25
Mizuho Securities
Reiterated
03/12/25
TD Cowen
Reiterated
03/05/25
Leerink Partners
Reiterated
03/04/25
KeyBanc
Reiterated
03/04/25
Benchmark Co.
Reiterated
03/04/25
Jefferies
Reiterated
03/03/25
Cantor Fitzgerald
Reiterated
02/03/25
Barclays
Assigned
01/29/25
Bank of America Securities
$30
Buy
25.26%
Upside
Assigned
12/16/24
Surgery Partners reinstated with a Buy at BofASurgery Partners reinstated with a Buy at BofA
J.P. Morgan
$38→$28
Hold
16.91%
Upside
Reiterated
12/03/24
Surgery Partners price target lowered to $28 from $38 at JPMorganSurgery Partners price target lowered to $28 from $38 at JPMorgan
Macquarie
―
Buy
―
Reiterated
11/19/24
Overreaction to Selloff: Surgery Partners' Undervalued Opportunity Amidst Strong Fundamentals
Citi
$38→$36
Buy
50.31%
Upside
Reiterated
08/07/24
Surgery Partners price target lowered to $36 from $38 at CitiSurgery Partners price target lowered to $36 from $38 at Citi
SGRY Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
3
4
4
1
1
Buy
6
7
9
6
11
Hold
2
3
3
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
14
16
9
14
Each month's total comprises the sum of three months' worth of ratings.
SGRY Financial Forecast
SGRY Stock Forecast FAQ
What is SGRY’s average 12-month price target, according to analysts?
Based on analyst ratings, Surgery Partners Inc.’s 12-month average price target is $32.67.
What is SGRY’s upside potential, based on the analysts’ average price target?
Surgery Partners Inc. has 36.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SGRY a Buy, Sell or Hold?
Surgery Partners Inc. has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
What is Surgery Partners Inc.’s price target?
The average price target for Surgery Partners Inc. is $32.67. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $36.00 ,the lowest forecast is $28.00. The average price target represents 36.41% Increase from the current price of $23.95.
The highest analyst price target is $36.00 ,the lowest forecast is $28.00. The average price target represents 36.41% Increase from the current price of $23.95.
What do analysts say about Surgery Partners Inc.?
Surgery Partners Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of SGRY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.